Influence of Bacterial Superantigen TSST-1 Against the Anti-Proliferative Efficacy of Immunosuppressive Drugs and Interleukin 2 Production in Peripheral Blood Mononuclear Cells of Hemodialysis Patients and Healthy Subjects

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Immunopharmacology and Immunotoxicology

• Publication date

  2008-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/08923970802135591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways.

  2007cited by this paper
• Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine.

  2007cited by this paper
• Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.

  2007cited by this paper
• Bacterial superantigen TSST-1 attenuates suppressive efficacy of glucocorticoids and calcineurin inhibitors against blastogenesis of peripheral blood mononuclear cells from patients with chronic renal failure on hemodialysis treatment.

  2007cited by this paper
• Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.

  2006cited by this paper
• Increased Sensitivities of Peripheral Blood Mononuclear Cells to Immunosuppressive Drugs in Cirrhosis Patients Awaiting Liver Transplantation

  2006cited by this paper
• Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance.

  2006cited by this paper
• Prevention of infectious complications in peritoneal dialysis: best demonstrated practices.

  2006cited by this paper
• IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly.

  2005cited by this paper
• Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway.

  2004cited by this paper
• Uremia-associated immune defect: the IL-10-CRP axis.

  2003cited by this paper
• Successful treatment of Staphylococcus aureus bacterial endocarditis in a renal transplant recipient

  2003cited by this paper
• A Novel ERK-dependent Signaling Process That Regulates Interleukin-2 Expression in a Late Phase of T Cell Activation*

  2003cited by this paper
• Immunosuppressant pharmacodynamics on peripheral-blood mononuclear cells from patients with ulcerative colitis.

  2002cited by this paper
• Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens.

  2000cited by this paper
• Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome

  2000cited by this paper
• The relationship between infection with group A beta hemolytic streptococci and the development of psoriasis.

  2000cited by this paper
• Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacy

  2000cited by this paper
• Lymphocyte sensitivity to cyclosporine and tacrolimus in chronic renal failure patients and clinical significance in renal transplantation.

  1998cited by this paper
• Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis

  1998cited by this paper
• Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks

  1997cited by this paper
• Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: Possible implications for individual therapeutic efficacy

  1997cited by this paper
• Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.

  1996cited by this paper
• Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents.

  1996cited by this paper
• Spontaneous bacterial peritonitis in a patient with nephrogenic ascites during an episode of acute renal transplant rejection.

  1996cited by this paper
• Gramicidin as a potential immunosuppressant for organ transplantation: suppression of human lymphocyte blastogenesis in vitro and prolongation of heart allograft survival in the rat.

  1995cited by this paper
• Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone.

  1994cited by this paper
• The Mechanism of Action of FK‐506 and Cyclosporin A

  1993cited by this paper
• Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responses.

  1991cited by this paper
• Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.

  1989cited by this paper

• No citing papers are available for this paper.